Multiple Site Testing Evaluation - Bayer HealthCare Ascensia Contour User Manual

Multiple Site Testing Evaluation

Forty persons with diabetes, in steady state for glucose,
performed self-capillary blood glucose assays using the
Ascensia C
ONTOUR
was performed with the Microlet Adjustable Lancing Device.
Samples from the palm, forearm, thigh, and abdomen were
obtained using the Ascensia™ M
Device. Ascensia C
compared to those obtained from the finger. One subject was
unable to obtain a sample from the abdomen. The blood
glucose range from the fingerstick measurements was 49 to
407 mg/dL, with an average of 166 mg/dL. The hematocrit
range was 36 to 52%, with an average of 42%.
A. Results from the Palm
600
500
400
300
200
100
0
0 100 200
Ascensia C
ONTOUR
34
System and one reagent lot. A fingerstick
results from the multiple sites were
ONTOUR
y=x
300 400 500
Fingerstick Result (mg/dL)
ICROLET
B. Results from the Forearm
600
500
400
300
200
100
0
600 0
Ascensia C
V ®
ACULANCE
100 200 300 400
Fingerstick Result (mg/dL)
ONTOUR
Lancing
y=x
500 600